David Friedecky PhD

Dr. David is the head of the group. His research focus covers metabolomics, lipidomics, and other fields of mass spectrometry in clinical research. In the routine diagnostic lab, he is responsible for LC-MS methods – newborn screening, therapeutic drug monitoring, and methods for diagnosis of inborn errors of metabolism (IEM).